FAP and neoplasm: Fibroblast activation protein (FAP) was initially described by Wolfgang Rettig in 1988 as a cell surface antigen expressed on reactive stromal fibroblasts within many epithelial cancers and in granulation tissue of wound healing, as well as on tumor cells of many sarcomas3.